Logo image of GANX

GAIN THERAPEUTICS INC (GANX) Stock Analyst Earnings Estimates

NASDAQ:GANX - Nasdaq - US36269B1052 - Common Stock - Currency: USD

1.44  -0.02 (-1.37%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
GANX revenue by date.GANX revenue by date.
160K
433.33%
140K
-12.50%
55.2K
-60.57%

-100.00%
22.387M94.119M
320.42%
238.71M
153.63%
386.2M
61.79%
EBITDA
YoY % growth
GANX ebitda by date.GANX ebitda by date.
-13.81M
-297.98%
-17.72M
-28.31%
-22.17M
-25.11%
N/A
8.58%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
GANX ebit by date.GANX ebit by date.
-13.83M
-297.41%
-17.78M
-28.56%
-22.253M
-25.16%
-22.651M
8.55%
-22.266M
-9.41%
-31.033M
-39.37%
-26.712M
13.92%
-35.889M
-34.36%
-10.363M
71.13%
44.775M
532.08%
162.33M
262.55%
285.13M
75.65%
Operating Margin
GANX operating margin by date.GANX operating margin by date.
-8,643.75%-12,700.00%-40,313.59%N/AN/AN/AN/AN/A-46.29%47.57%68.00%73.83%
EPS
YoY % growth
GANX eps by date.GANX eps by date.
-1.51-1.48
1.99%
-1.78
-20.27%
-0.98
48.31%
-0.64
30.71%
-0.74
-15.52%
-0.73
0.97%
-1.27
-74.13%
-0.36
71.89%
-0.361.69
574.29%
3.90
130.12%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26
EPS
Q2Q % growth
-0.17
59.12%
-0.15
12.00%
-0.16
-46.82%
-0.16
-2.00%
Revenue
Q2Q % growth
51K
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
-5.028M
38.55%
-5.59M
-25.36%
-6.494M
-94.96%
-11.165M
-127.85%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
-0.16
27.27%
-0.180.0212.85%
Q4 2024
Q2Q % growth
-0.11
69.44%
-0.190.0841.18%
Q3 2024
Q2Q % growth
-0.17
54.05%
-0.220.0522.48%
Q2 2024
Q2Q % growth
-0.42
32.26%
-0.20-0.22-105.88%
Q1 2024
Q2Q % growth
-0.22
48.84%
-0.300.0826.26%
Q4 2023
Q2Q % growth
-0.36
7.69%
-0.33-0.03-9.44%
Q3 2023
Q2Q % growth
-0.37
2.63%
-0.450.0818.67%
Q2 2023
Q2Q % growth
-0.62
-44.19%
-0.31-0.31-97.67%
Q1 2023
Q2Q % growth
-0.43
-53.57%
-0.40-0.03-7.18%
Q4 2022
Q2Q % growth
-0.39
-21.88%
-0.390.00-1.29%
Q3 2022
Q2Q % growth
-0.38
2.56%
-0.470.0919.01%
Q2 2022
Q2Q % growth
-0.43
-43.33%
-0.32-0.11-34.54%
Q1 2022
Q2Q % growth
-0.28
44.00%
-0.370.0925.30%
Q4 2021
Q2Q % growth
-0.32 -0.500.1835.54%
Q3 2021
Q2Q % growth
-0.39 -0.36-0.03-7.20%
Q2 2021
Q2Q % growth
-0.30 -0.310.013.57%
Q1 2021
Q2Q % growth
-0.50 -0.22-0.28-128.00%
GANX Yearly EPS VS EstimatesGANX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 3
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
25.5K-25.5K-100.00%
Q2 2024
Q2Q % growth
408K-408K-100.00%
Q1 2024
Q2Q % growth

-100.00%
30.6K-30.6K-100.00%
Q4 2023
Q2Q % growth
331.5K-331.5K-100.00%
Q3 2023
Q2Q % growth
280.296K-280.296K-100.00%
Q2 2023
Q2Q % growth

-100.00%
1.034M-1.034M-100.00%
Q1 2023
Q2Q % growth
55K
10.00%
55K%
Q4 2022
Q2Q % growth

-100.00%
12.75K-12.75K-100.00%
Q3 2022
Q2Q % growth

-100.00%
58.905K-58.905K-100.00%
Q2 2022
Q2Q % growth
100K
11.11%
27.877K72.123K258.72%
Q1 2022
Q2Q % growth
50K
400.00%
39.78K10.22K25.69%
Q4 2021
Q2Q % growth
40K 52.53K-12.53K-23.85%
Q3 2021
Q2Q % growth
30K 13.597K16.403K120.64%
Q2 2021
Q2Q % growth
90K
800.00%
90K%
Q1 2021
Q2Q % growth
10K 10K%
GANX Yearly Revenue VS EstimatesGANX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2029 2030 2031 2032 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -1.41% 11.76% 20.89%
Revenue0% 0% -100% -100%